首页 | 本学科首页   官方微博 | 高级检索  
     

磷结合剂在终末期肾病中的应用
引用本文:陈越,钟一红,丁小强. 磷结合剂在终末期肾病中的应用[J]. 复旦学报(医学版), 2007, 34(5): 790-792
作者姓名:陈越  钟一红  丁小强
作者单位:复旦大学附属中山医院肾内科,上海,200032;复旦大学附属中山医院肾内科,上海,200032;复旦大学附属中山医院肾内科,上海,200032
摘    要:终末期肾病患者普遍存在高磷血症,而高磷血症是终末期肾病患者死亡率和心血管疾病发生率增高的重要因素。另外高磷血症还可引起甲状旁腺功能亢进、骨营养不良、转移性钙化等,因此有效控制血清磷水平是终末期肾病一体化治疗的重要措施。目前高磷血症的治疗主要包括饮食限磷、透析治疗、磷结合剂的应用及必要时甲状旁腺的切除。本文将具体介绍各种磷结合剂用于治疗高磷血症的研究进展。

关 键 词:磷结合剂  终末期肾病  高磷血症
修稿时间:2006-12-06

Application of phosphate binder to end-stage renal disease
CHEN Yue,ZHONG Yi-hong,DING Xiao-qiang. Application of phosphate binder to end-stage renal disease[J]. Fudan University Journal of Medical Sciences, 2007, 34(5): 790-792
Authors:CHEN Yue  ZHONG Yi-hong  DING Xiao-qiang
Abstract:Patients with end-stage renal disease(ESRD) commonly experience hyperphosphatemia.Hyperphosphatemia is an important cause to increase mortality and incidence of cardiovascular diseases for patients with ESRD.In addition,hyperphosphatemia can lead to hyperparathyroidism,osteodystrophy,metastatic calcification,and so on.Therefore,it is important to control serum phosphorus levels effectively in generalized treatments of ESRD.At present,treatments of hyperphosphatemia include dietary restrictions,dialysis,treatment with phosphate binders,and parathyroidectomy when necessary.This article introduces the progress of phosphate binders in detail.
Keywords:phosphate binder  end-stage renal disease  hyperphosphatemia
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号